Additionally, these drugs exhibit antiproliferative effects involving cell cycle regulators, lysosomal enzymes, or growth factors (e.g., matrix metallopeptidase 9 and vascular endothelial growth factor), which are known to participate in tumor growth and metastasis (details in Table 1) [24]. This evidence concerns the gene MMP9 and neoplasm.